Sign in
4

Changes in Ownership

LENZ Therapeutics, Inc. Filed Acc 0000950170-25-092373

10% owner sold 200,000 shares at $30.47 ($6,093,000)

From the SEC's structured data for this filing

Trades in this filing

Versant Venture Capital VI, L.P. · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-06-27 Sale : show line 1 in the form −200,000 $30.47 $6,093,000 1,767,275 D
Open-market sales · 200,000 sh · avg $30.47 · $6,093,000
Loading xslF345X05/ownership.xml…